Table 2. Clinicopathological characteristics of patients from Chinese and Bangladeshi cohorts.
Patient ID | Gender | Age | Cellular type | Differentiation stage | Portal vein infiltration | |
Chinese | 1 | Male | 48 | HCC | Middle | Yes |
4 | Male | 31 | HCC | Low | Yes | |
5 | Female | 69 | HCC | Middle | Yes | |
6 | Male | 51 | HCC | Middle | Yes | |
7 | Male | 80 | HCC | Middle to low | Yes | |
8 | Male | 43 | HCC | High | No | |
9 | Male | 50 | HCC | Middle | No | |
10 | Male | 44 | HCC | High | No | |
11 | Male | 73 | HCC | Middle to low | No | |
12 | Female | 51 | HCC | Middle to high | No | |
13 | Male | 40 | Inflammatory pseudotumor | - | No | |
14 | Male | 52 | HCC | Middle | No | |
15 | Male | 31 | HCC | Middle | No | |
Bangladeshi | 1 | Male | 22 | CHB | - | - |
2 | Male | 48 | HCC | - | - | |
3 | Male | 35 | CHB | - | - | |
4 | Male | 29 | CHB | - | - | |
5 | Male | 35 | HCC | - | - | |
6 | Male | 55 | HCC | - | - | |
8 | Male | 20 | CHB | - | - | |
9 | Male | 34 | HCC | - | - |